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Background: Esophageal atresia (EA), tracheoesophageal fistula (TEF), or both is a complicated problem. The purpose
of this study was to evaluate the outcomes and postoperative complications in patients with EA/TEF who were admitted
to our hospital.
Methods: In total, 15 patients were enrolled from 1994 to 2003, including 8 males and 7 females. Patient demograph-
ics, associated anomalies, and outcomes were analyzed.
Results: The most common variant was EA with a distal TEF (type C), which occurred in 12 patients (80%). The latter had
associated congenital anomalies, and cardiac anomalies were the most frequent, occurring in 8 patients (53.3%). Of the
6 cases who had life-threatening anomalies, 4 (66.7%) died, and of the 9 cases who had no life-threatening anomalies,
2 (22.2%) died. Tracheomalacia and/or stenosis were diagnosed in 8 patients (66.7%) postoperatively. Though 3 of the
4 cases who suffered from dying spell received intratracheal stent implantation, 2 cases still died.
Conclusion: The survival rate of the patients with EA/TEF is influenced mainly by associated life-threatening anomalies.
TMS combined with a history of dying spell may be the major fatal complication. [J Chin Med Assoc 2006;69(7):317–321]
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Introduction
Congenital esophageal atresia (EA) and tracheoeso-
phageal fistula (TEF) are well-known congenital anom-
alies which affect 1 in 2,400–4,500 live births.1 The
survival of infants born with both EA and TEF (EA/
TEF) has dramatically improved since Cameron
Haight’s first report of successful surgical correction in
1941.2 Improvement of survival is multifactorial and
largely attributable to the advances in neonatal inten-
sive care, anesthetic management, ventilatory support,
and surgical techniques over the past decades. Survival
can even be achieved in low birth weight infants,3 and
mortality is currently limited to those with coexistent
severe life-threatening anomalies.
Despite the improvement in survival, the morbidity
associated with surgical repair remains high.4 In this
study, we review our previous 10-year experience of
patients with EA/TEF. The results may be beneficial
for further clinical management of these patients in
future.
Methods
Patients who had been admitted to Taipei Veterans
General Hospital with a diagnosis of EA/TEF between
1994 and 2003 were enrolled. We retrospectively ana-
lyzed their medical record charts. Their anatomical clas-
sification was based on the Gross classification (type
A–D, plus H-type TEF).5
These infants were also classified into the following
risk groups with Waterston and associates’ method:
group A, birth weight >2,500 g and well; group B,
birth weight 1,800–2,500 g and well or birth weight 
>2,500 g but with pneumonia and other congenital
anomalies; and group C, birth weight <1,800 g or birth
weight >1,800 g with severe anomalies or pneumonia.
Patient demographics, associated anomalies, post-
operative complications, and outcomes were studied.
The follow-up period ranged from 14 months to 10
years.
Results
In total, 15 patients, 8 males (53.3%) and 7 females
(46.7%), were enrolled. The mean gestational age was
37 ± 3.2 weeks (range, 27–41 weeks) and the mean
birth weight was 2,491 ± 708 g (range, 770–3,825 g).
There were 3 preterm infants (gestational age <37
weeks, 20%) and 5 babies were small for gestational age
(2 standard deviations below the mean weight for
gestational age, 33.3%).
Patient characteristics and associated anomalies are
shown in Table 1. By the Gross classification, the most
common type was EA with a distal TEF (type C), which
occurred in 12 of the 15 cases (80%). Among the 3
remaining patients, the first was pure EA (type A), the
other was H-type TEF without EA, and the third was
tracheal atresia with distal fistula (non-type). By risk
groups with Waterston and associates’ method: group A,
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Table 1. Patients demographics and associated anomalies
Case Sex GA (wk) BBW (g) Type* Group† Operation Anomalies Survival
1 F 36 1,910 C B Yes Yes
2 M 38 2,430 C B Yes Yes
3 M 40 3,030 C A Yes Microtia Yes
4 F 35 2,500 A B Yes Dextrocardia Yes
Right lung hypoplasia
5 F 37 2,100 C C Yes TOF, MAPCA Yes
Bronchial stenosis
6 F 39 3,080 C B Yes Type II VSD Yes
Conductive hearing loss
7 F 39 2,730 C B Yes Hypothyroidism Yes
8 M 39 3,825 C A Yes Yes
9 M 39 2,250 C C No VACTERL syndrome: No
TOF
Imperforate anus
Scoliosis
Polydactyl
10 M 39 2,700 Tracheal C Yes VACTERL syndrome: No
atresia/distal DORV
TEF Type II VSD, PS, PDA
Subglottic stenosis
Rectourethral fistula
Imperforate anus
11 F 41 2,680 C B Yes Without left thumb, PDA No
12 M 39 1,680 C C No Trisomy 18 No
13 F 27 770 C C No Cataract No
14 M 40 2,680 C C Yes Laryngeal cleft No
Bronchial stenosis
Subglottic stenosis
15 M 37 3,000 H C Yes Double aortic arch No
Type II VSD, ASD, PDA,
bilateral PPS
Tracheomalacia
Bronchial stenosis
Cleft palate
*Gross classification; †Waterston and associates’ method. GA = gestational age; BBW = birth body weight; TOF = tetralogy of Fallot; MAPCA = major aortopul-
monary collateral arteries; VSD = ventricular septal defects; VACTERL = vertebral anomalies, anal atresia, cardiac defect, tracheoesophageal fistula, renal
abnormalities, and limb abnormalities; DORV = double outlet of right ventricle; PS = pulmonic stenosis; PDA = patent ductus arteriosus; ASD = atrial septal
defects; PPS = peripheral pulmonic stenosis.
2 patients (13.3%); group B, 6 patients (40%); and group
C, 7 patients (46.7%). Most patients in our study were
in higher risk groups, especially groups B and C.
As shown in Table 2, 12 patients (80%) had associ-
ated congenital anomalies. Cardiac anomalies were the
most frequent, occurring in 8 patients (53.3%). Airway
and lung anomalies occurred in 5 patients (33.3%),
which included right lung hypoplasia, bronchial steno-
sis, laryngeal cleft, subglottic stenosis, and tracheo-
malacia/stenosis (TMS). Head and neck anomalies
occurred in 3 patients (25.0%), which included microtia,
cleft palate, and conductive hearing loss. Gastro-
intestinal anomalies occurred in 2 patients (13.3%)
and both were imperforate anus. Skeletal deformities
occurred in 2 patients (16.7%): 1 was polydactyly and
scoliosis, and the other was absence of left thumb. Major
genitourinary tract anomaly occurred in 1 patient
(6.7%), diagnosed as rectourethral fistula. Metabolic
disease occurred in 1 patient (6.7%) who had hypothy-
roidism. Ophthalmologic anomaly of cataract occurred
in 1 patient (6.7%). Three cases were also diagnosed
with chromosomal anomalies: 1 trisomy 18 and 2
VACTERL syndromes. Severe life-threatening anom-
alies, which mean fatal anomalies of vital organs, espe-
cially the cardiac system, were noted in 6 patients
(40%: cases 4, 5, 9, 10, 12, 15).
Three patients died before definitive surgical repair
operation. Two had chromosomal anomalies (cases 9,
12) and were given up by the family. The third patient
died from complications of extreme prematurity (case
13). In total, 12 patients had received surgical cor-
rection in our hospital. Five of them (cases 1, 2, 4, 7,
14) were transferred from other hospitals. Of these 
5 patients, 3 (cases 1, 2, 14) suffered anastomotic leaks
with recurrent TEF after primary surgery and the
repair procedures were done at our hospital. One
patient (case 4, type A), referred after preliminary gas-
trostomy and esophagostomy, received reconstruction
with right colon later in our hospital. One patient (case
7) got severe stricture at the anastomosis of esophagus
after the first surgery and received repair procedure in
our hospital. Of the remaining 7 patients, 6 underwent
primary esophageal anastomoses within the first 48
hours after birth, and 1 underwent repair of H-type
fistula 39 days after birth.
Complications after surgery are shown in Table 3.
Postoperative TMS was found in 8 patients diagnosed
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Table 2. Associated anomalies in 15 EA/TEF patients
Anomaly n
Cardiac (n = 8)
PDA 3
VSD 3
TOF 2
PS/PPS 2
ASD 1
Dextrocardia 1
Double aortic arch 1
DORV 1
MAPCA 1
Airway and lung (n = 5)
Bronchostenosis 3
Subglottic stenosis 2
Right lung hypoplasia 1
Laryngeal cleft 1
Tracheomalacia 1
Syndromes (n = 3)
VACTERL 2
Trisomy 18 1
Head and neck (n = 3)
Microtia 1
Cleft palate 1
Conductive hearing loss 1
Skeletal (n = 2)
Polydactyly 1
Left thumb absence 1
Scoliosis 1
GI system (n = 2)
Imperforate anus 2
GU system (n = 1)
Rectourethral fistula 1
Metabolic disease (n = 1)
Hypothyroidism 1
Ophthalmologic (n = 1)
Cataract 1
PDA = patent ductus arteriosus; VSD = ventricular septal defects; TOF = tetralogy
of Fallot; PS = pulmonic stenosis; PPS = peripheral pulmonic stenosis; ASD =
atrial septal defects; DORV = double outlet of right ventricle; MAPCA = major aor-
topulmonary collateral arteries; VACTERL = vertebral anomalies, anal atresia,
cardiac defect, tracheoesophageal fistula, renal abnormalities, and limb abnor-
malities; GI = gastrointestinal; GU = genitourinary.
Table 3. Complications after surgery in 12 EA/TEF patients
Complications n (%)
Tracheomalacia/stenosis 8 (66.7)
Recurrent pneumonia 6 (50.0)
Gastroesophageal reflux 6 (50.0)
Anastomotic leak 4 (33.3)
Dying spell 4 (33.3)
Anastomotic stricture 2 (16.7)
Recurrent TEF 0 (0.0)
by flexible airway endoscopy. Four patients with TMS
manifested dying spell or feeding spell (cases 2, 5, 14,
15), and 1 of them also showed the coexistence of
esophageal stricture (case 5). Tracheal stents were
deployed in 3 dying spell patients, and 2 of them still
suffered recurrent desaturation, respiratory distress
and failure after the stenting, and finally died (cases
14, 15). One patient survived tracheal balloon dilata-
tions done twice (case 5). Recurrent pneumonia (>–3
infections per year) occurred in 6 patients (50%) and
1 received lobectomy. Gastroesophageal reflux (GER)
was found in 6 patients (50%), 2 of them received
antireflux procedures. Anastomotic leakage occurred
in 4 patients (33.3%). Anastomotic strictures, defined
as an anastomotic narrowing that required dilatations 
or reoperation, occurred in 2 patients (16.7%) at esopha-
goesophageal (EE) and esophagocolonic (EC) anasto-
moses. Balloon dilatation was done in 1 patient and
reoperation in the other.
During the follow-up period, 7 patients (46.7%)
died. Four patients died after surgical repair, 2 of
whom had experienced dying spell (cases 14, 15).
Four of the 6 patients with life-threatening anomalies
(66.7%) died. In 9 cases who had no life-threatening
anomalies, only 2 (22.2%) died. The survival rate in
each risk group of A, B and C were 100%, 83.3% and
14.3%, respectively.
Discussion
Several studies have reported the variety of postoperative
complications and outcomes in EA/TEF patients.4–8
Respiratory complications were associated with TMS
(11–62%), dying spell (2.7%), and recurrent pneumonia
(90%).4,7,9 Gastrointestinal complications included GER
(35–95%) and esophageal stenosis (17– 40%).5,10 Others
were anastomotic leakage (8.5–36%), recurrence of fis-
tula (4–10%), and anastomotic stricture (8–37%).5–8
The association of TMS with EA/TEF has been
well recognized. It is present in pathologic specimens in
75% of EA/TEF patients.7,11 In our series, it was diag-
nosed in 8 patients (66.7%). The rate was higher than in
the earlier studies,4,7 but a bit higher than the recent
study10 because dynamic flexible airway endoscopy for
the routine check of the whole airway in these patients
was recently used in our hospital. Thus, we could detect
more dynamic changes in TMS cases, which may other-
wise be missed by computed tomography study. “Dying
spell” means patients with TMS getting apnea and
cyanosis, especially when they feed, cry, or cough, 
and can be the most serious problem associated with
TMS. When TMS is severe enough to induce obvious
clinical symptoms (dyspnea, cyanosis, or recurrent
pneumonia), aggressive intervention should not be
delayed.12,13 Patients who have esophageal stenosis
can cause more serious problem because the food bolus
may stack at the proximal site of the stenosis. This
bulging pouch may anteriorly compress the membra-
nous portion of the trachea, resulting in tracheal lumen
block, then inducing apnea and hypoxia. In our series, 
4 cases (33.3%) were diagnosed as having dying spell.
The incidence was higher compared with the other
report7 as we treated the transferred cases (cases 2, 14)
with recurrent TEF and anastomotic strictures who had
a higher possibility of getting dying spell after reopera-
tion, and case 15, another dying spell case, noted to
have TMS before surgery, had the condition worsen
after the total correction. Three of the 8 TMS cases
with dying spell had received tracheal stent placement,
and 2 of them died. One survived and the stent was
removed successfully 1 year later. Another TMS patient
with dying spell, no stent deployed, received tracheal
balloon dilatations twice and had normal respiratory
status in the follow-up period.
Esophageal dysmotility and GER are common
sequelae in patients who have undergone repair of
EA/TEF. In our series, 6 cases (50%) were diagnosed
with GER. The incidence was higher than some, but
not all reports4,7,10 because we had more complicated
transferred cases (cases 2, 7, 14) who required reop-
eration that might have worsened the intrinsic motor
function of the esophagus. Chittmittrapap et al4
showed that GER could significantly increase the
esophageal stricture rate. Two of the GER cases had
strictures over the site of anastomosis. We advocate
early detection and treatment of GER to reduce post-
operative stricture rate.
The reported incidence of recurrent TEF ranges
from 3 to 12%.4–5 The pathogenesis of recurrent TEF
can be an anastomotic suture leakage with further ero-
sion through the previous repair site. All the 3 cases
with recurrent TEF in our series were transferred from
other hospitals after the primary surgery, and came
for further surgical repair.
In 1962, Waterston et al14,15 devised the first clas-
sification systems for EA/TEF. Risk factors included
low birth weight, pneumonia, and associated anomalies.
Our study discloses different survival rates among
groups A, B and C patients (100%, 83.3% and 14.3%,
respectively). We demonstrated that this classification
may predict outcomes, but the number of our patients
is not large enough to make a statistically significant
differentiation.
The management of infants with isolated EA (type
A) is often complex and presents a challenge for 
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pediatric surgeons. The operative morbidity asso-
ciated with esophageal replacement procedure is
high.5,16,17 In addition to the anastomotic leakages,
strictures, and graft ischemia, the other late complica-
tions include GER, recurrent aspiration, esophageal
dysmotility, swallowing problems, ulceration, bleeding,
respiratory tract infections, and failure to thrive.5,17–19
One case of isolated EA in our series had received
reconstruction with right colon, which was compli-
cated with esophageal stricture, and who subsequently
had balloon dilatations done 4 times, suture site 
leakage, recurrent pneumonia, and pneumonectomy.
She is 11-years-old and has normal respiratory status
without any other complications. The mortality rate
in our series is higher than in other reports7,8 because
of the more complicated nature of the transferred
cases.
We conclude that the survival rate of patients with
EA/TEF was influenced mainly by associated life-
threatening anomalies and postoperative TMS with
dying spell. Therefore, we suggest that EA/TEF
patients with clinical respiratory distress should be
evaluated aggressively by flexible airway endoscopy
that can be used not only for early diagnosis but also
for intervention.
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